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SUMMARY · Among all endoscopically removed gastric polypoid lesions, more than 75% are true
gastric epithelial polyps. They are divided into hyperplastic, glandular cystic and adenomatous pol-
yps. Adenomatous polyp is a true neoplastic polyp, and hyperplastic polyp carries a risk of malignant
alteration. Based on the present knowledge, an algorithm for the clinical management of benign
epithelial gastric polyps is proposed.
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Introduction
Gastric polyps are pedunculated or sessile lesions that
project into the gastric lumen1. True gastric epithelial
polyps account for more than 75% of all endoscopically
removed gastric polypoid lesions2. Although data on the
prevalence of gastric polyps still are quite inconsistent,
they do not seem to be common1. Gastric polyps are found
in 0.12% to 3.38% of the patients undergoing upper en-
doscopy1,3. However, gastric polyps are an important en-
tity because of their malignant potential4-7.
Although patients with gastric polyps may present
with nonspecific symptoms such as upper gastrointesti-
nal tract bleeding, abdominal pain, or gastric outlet ob-
struction, up to 50% of the polyps are detected inciden-
tally on endoscopy for the symptoms unrelated to the
presence of gastric polyp.
Endoscopic appearance is an unreliable predictor of
the polyp histology. As the foci of dysplasia may be missed
on biopsy, gastric polyps, and larger ones in particular,
should be completely removed to obtain definite diagno-
sis8.
Recent data show that intestinal metaplasia, atrophic
gastritis and/or Helicobacter (H.) pylori infection can be
associated with certain types of polyps and at the same
time recognized as markers of their malignancy. On the
basis of these facts, some new therapeutic approaches have
been proposed5,9-12. So, biopsy of the nonpolypoid sur-
rounding gastric mucosa has also been inaugurated as a
new standard11.
Classification and Malignant Potential
According to the World Health Organization (WHO),
the hyperplastic and neoplastic types of benign epithelial
gastric polyps can be distinguished3. Hyperplastic polyps
are further divided into two different subtypes, i.e. polypoid
foveolar hyperplasia, a lesion that has no malignant poten-
tial at all, and typical hyperplastic polyp. However, this
equivocal definition of ‘hyperplasiogenous’ (hyperplastic)
polyp remains quite inconsistent. Stolte et al.2 stress that
differentiation of hyperplastic polyps from foveolar hyper-
plasia is important regarding their different malignant po-
tential, showing disagreement with the WHO classifica-
tion in which these two polyp types are considered together
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under the term ‘hyperplastic polyp’. We also find histologic
differentiation very important, especially concerning its
impact on further therapy and surveillance.
Hyperplastic polyps account for approximately 25% of
gastric polyps. They may be located anywhere, sizing 1 cm
on an average12. They are considered regenerative in their
nature, and in fact, they are a proliferative-reparative re-
sponse to chronic inflammation and epithelial injury in
most of the cases associated with chronic active gastritis and
concomitant infection with H. pylori1,4,13. Eradication of H.
pylori infection associated with the presence of hyperplas-
tic gastric polyp resulted in complete polyp regression in
more than 40% of patients, especially the polyps of <1 cm
in size13. In larger series, the rate of liability of hyperplas-
tic gastric polyps to malignant changes varied from 0.3%
to 7.1%, mean 2.1%, even in those smaller than 2 cm3.4.
Despite the fact that a strong relationship between malig-
nant transformation and the size of hyperplastic gastric
polyps has not been elucidated, and that it has also been
described for adenomatous polyps, dysplasia and carcinoma
are more likely to be found in the polyps of >2 cm in di-
ameter2.
The incidence of synchronous or metachronous car-
cinomas in patients with solitary hyperplastic polyps varies
considerably from 1.2% to 28%1,13. They are closely re-
lated to the presence of atrophic gastritis, and atrophy
progression is more rapid in patients with hyperplastic
polyps than in control subjects without polyps1. Focal
intestinal metaplasia is found in 16% of cases11.
The neoplastic type is adenomatous polyp found in
10% of gastric polyps in most series5. The percentage of
focal carcinoma in adenomas has been reported to range
between 1.4% and 75.0%, mean 41.0%. During a 49-
month follow-up, malignant transformation was found in
11% of the gastric adenomas examined5.
The risk of carcinomatous transformation is size-de-
pendent: a polyp size of >2 cm has been suggested to be
critical on determination of the adenomatous polyp ma-
lignant potential2. The presence of severe epithelial dys-
plasia, villous appearance, and large size have also been
found to correlate with an increased malignant potential5.
Although no close relationship between H. pylori infec-
tion and gastric adenoma has been demonstrated13, H.
pylori eradication has been suggested as being likely to
inhibit the progression of gastric adenoma to carcinoma9.
However, the adenoma-carcinoma sequence has not been
established, although the bcl-2 deletion, p-53 mutation
and c-erbB2 gene amplification have been found to oc-
cur at a relatively high frequency in patients with gastric
adenomas. It has not yet been fully clarified whether these
are just late events in cancer development. Sulfomucin
appears to correlate well with the malignant appearance
of gastric polyps, and the relationship between the sub-
type of intestinal metaplasia in the polyps with sulfomucin
production and gastric carcinoma is evident5. Follow-up
is mandatory in these patients3,12.
Gastric adenoma is usually associated with synchro-
nous gastric carcinoma in 8% to 59% of cases3,6.
The third type is known as fundic gland polyp or
Elster’s glandular cyst2. Some authors have not taken it
into account since the thesis on their hamartomatous but
not hyperplastic or neoplastic nature is still valid3. These
are most common gastric polyps (50%), and are always
associated with normal gastric mucosa2,12. Fundic gland
polyps have no malignant potential. Their significance lies
in their correlation with colonic adenoma, so the patient
should undergo colonoscopy1.
Therapeutic Approach
The introduction of endoscopy with its associated fa-
cilities for biopsy and polypectomy have greatly improved
the diagnosis and therapy of gastric polyps, which, on the
basis of radiologic diagnosis, were treated surgically in the
pre-endoscopic era2. Current methodology includes de-
tailed examination of the stomach after good insufflation,
which is necessary to diagnose small fundic polyps, and
biopsies of the polyp as well as of the surrounding mu-
cosa12. While most endoscopists agree that large polyps
or those associated with metaplasia should be removed
either endoscopically or surgically, the management of
small or asymptomatic gastric polyps remains a contro-
versial issue. Forceps biopsy is usually sufficient when
polyps are relatively small, generally smaller than 1 cm.
Some authors recommend ‘jumbo’ biopsy forceps for di-
minutive polyps (5 mm)8. Histologic diagnosis of foveo-
lar hyperplasia excludes polypectomy, however, in case of
hyperplastic or adenomatous polyps larger than 1 cm en-
doscopic polypectomy, typing of gastritis and regular fol-
low-up examination are the recommended procedures14.
As hyperplastic polyps occur in association with various
forms of chronic gastritis, particularly autoimmune gas-
tritis and H. pylori gastritis, eradication of the latter is also
recommendable. It can lead to the complete regression of
hyperplastic polyps, particularly of those of <1 cm in di-
ameter11. On the other hand, particularly in case of larger
polyps, polypectomy seems to be a definite treatment13.
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Fig. 1. Optimal strategy for the management of benign epithelial gastric polyps
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These techniques are generally safe, and can be performed
in an outpatient setting. The complications (bleeding,
perforation, and abdominal pain) are rarely encountered8.
An important issue is the fact that, in larger polyps, for-
ceps biopsy sampling for polyp histology suffers from
‘sampling error’, and may fail to characterize the polyp
histology correctly8,15. It has been reported that histologic
diagnosis of biopsy material was modified in 75% of cases
after polypectomy8. Therefore, if a gastric polyp is larger
than 1 cm, then polypectomy is strongly indicated. Irre-
spective of the type and grade of dysplasia, adenomas of
gastric mucosa should always be removed in toto14. The
follow-up after polypectomy or even mucosectomy should
be planned on the basis of histologic finding and grading
of dysplasia. Follow-up is not necessary if no dysplasia was
found. In case of mild to moderate dysplasia, follow-up
is recommended in 3- to 5-year intervals. If severe dys-
plasia is found, the follow-up period is 6 months. An
optimal strategy for the management of patients with
benign epithelial gastric polyps is presented in Fig. 1.
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Saæetak
KLINI»KI PRISTUP BENIGNIM EPITELIJSKIM ÆELU»ANIM POLIPIMA
I. KovaËeviÊ, N. LjubiËiÊ, M. Makitan i D. ©tajduhar
Od svih endoskopski odstranjenih polipoidnih izraslina æeluca oko 75% Ëine pravi æeluËani polipi. Prema histolo¹kom tipu
dijele se na hiperplastiËne, ælijezdane cistiËne i adenomatozne polipe. Adenomatozni polipi su prave neoplazme, dok hiperplastiËni
polipi nose rizik maligne promjene. Na osnovi sada¹njih spoznaja prikazan je algoritam lijeËenja æeluËanih epitelijskih polipa.
KljuËne rijeËi: Polipi, dijagnoca; Polipi, terapija; ÆeluËane bolesti, patologija; Endoskopija, gastrointestinalna
